Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INTREPID: Trelegy Ellipta vs Non-ELLIPTA MITT in COPD
NCT03467425Phase 4Completed
- Sponsor
- GSK
- Start
- Apr 2018
- Primary completion
- Oct 2019
- Modality
- Orthosteric Ligands
- Countries
- 5
01
Overview
A Phase 4 trial of fluticasone in chronic obstructive pulmonary disease (COPD), sponsored by GSK. Started Apr 2018; status: completed.
02
Drugs
fluticasone
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT03467425.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03467425.